AGIOS PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2012 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.1M, a 22.8% increase year-over-year.
  • Agios Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $45.8M, a 7.88% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.8M, a 9.19% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $49.3M, a 7.87% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $53.5M, a 13.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $45.8M $11.1M +$2.07M +22.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $43.7M $11.6M -$172K -1.47% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $43.9M $9.23M -$905K -8.93% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $44.8M $13.8M +$2.35M +20.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $42.4M $9.08M -$2.08M -18.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $44.5M $11.7M +$572K +5.12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $43.9M $10.1M -$5.37M -34.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $49.3M $11.5M -$156K -1.34% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $49.5M $11.2M -$992K -8.17% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $50.4M $11.2M -$3.72M -25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $54.2M $15.5M +$656K +4.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $53.5M $11.6M -$1.72M -12.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $55.2M $12.1M -$2.83M -18.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $58.1M $14.9M -$2.73M -15.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $60.8M $14.9M -$816K -5.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $61.6M $13.3M +$10.5M +375% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $51.1M $15M -$3.61M -19.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $54.7M $17.6M -$933K -5.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $55.6M $15.7M -$2.44M -13.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $58.1M $2.81M -$15.4M -84.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $73.4M $18.6M -$5.61M -23.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $79M $18.5M +$2.09M +12.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $76.9M $18.1M +$3.59M +24.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $73.4M $18.2M +$5.51M +43.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $67.9M $24.2M +$12M +98.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $55.9M $16.5M +$4.27M +35% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $51.6M $14.5M +$3.79M +35.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $47.8M $12.7M +$2.84M +28.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $45M $12.2M +$64K +0.53% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $44.9M $12.2M +$1.19M +10.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $43.7M $10.7M +$1.63M +17.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $42.1M $9.84M +$486K +5.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-14
Q3 2016 $41.6M $12.1M +$2.77M +29.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $38.8M $11M +$2.82M +34.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $36M $9.11M +$4.05M +80% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $32M $9.35M +$4.63M +97.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-14
Q3 2015 $27.3M $9.37M +$6.48M +224% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $20.9M $8.18M +$5.8M +243% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $15.1M $5.06M +$3.56M +236% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $11.5M $4.73M +$3.56M +306% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-16
Q3 2014 $7.94M $2.89M +$1.78M +160% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $6.16M $2.38M +$2.05M +624% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $4.11M $1.51M +$1.08M +255% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $3.03M $1.17M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $1.11M +$942K +554% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $329K +$238K +262% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $424K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q3 2012 $170K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $91K Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.